Table 1. Base line of patients.

Characteristic	Value
Cases	14
Gender(cases/percent) male Female	6/43 8/57
Age(year) Range Media	31-70 56
Primary or metastases (cases/percent) Primary Metastases	0 14
Primary site (cases/percent) Lung Breast Lymphoma Gastric cancer	11/78.6 1/7.1 1/7.1 1/7.1
WBRT (cases/percent) Yes No	4/28.6 10/71.4
Dose(cGy) Range Media	1400-4000 2600
Dose line(%) Range Media	50-82 75
Fractions Range Media	1-5 2
BED (cGy) Range Media	5980-9880 7590
History of bevacizumab use Yes No	2 12
frequency of bevacizumab Range Media	3-10 3
Dose of bevacizumab	5mg/kg q3-4w
Follow time(months) Range Media	4.3-39.1 12.3